Related references
Note: Only part of the references are listed.Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters
Weiwei Xue et al.
CURRENT MEDICINAL CHEMISTRY (2020)
New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative
Giacomo Rossino et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter
Liang Xu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor
Ara M. Abramyan et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice
Melissa A. Tapia et al.
PSYCHOPHARMACOLOGY (2019)
More bang for your buck: Improved use of GPU nodes for GROMACS 2018
Carsten Kutzner et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2019)
Monoamine transporters: structure, intrinsic dynamics and allosteric regulation
Mary Hongying Cheng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Substrate-induced conformational dynamics of the dopamine transporter
Anne Kathrine Nielsen et al.
NATURE COMMUNICATIONS (2019)
Transporter oligomerisation: roles in structure and function
Cristina Cecchetti et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands
Youyi Peng et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Structure and Gating Dynamics of Na+/CI- Coupled Neurotransmitter Transporters
Deepthi Joseph et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays
Hideaki Yano et al.
NEUROPHARMACOLOGY (2018)
The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction
Danielle O. Sambo et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder
Weiwei Xue et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Structural basis for σ1 receptor ligand recognition
Hayden R. Schmidt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats
Weimin Conrad Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle O. Sambo et al.
NATURE COMMUNICATIONS (2017)
Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD
Panpan Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies
Panpan Wang et al.
ACS CHEMICAL NEUROSCIENCE (2017)
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field
Jumin Lee et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Crystal structure of the human σ1 receptor
Hayden R. Schmidt et al.
NATURE (2016)
The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands
Ashish K. Mishra et al.
BIOCHEMICAL JOURNAL (2015)
Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities
Juan Zhen et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Neurotransmitter and psychostimulant recognition by the dopamine transporter
Kevin H. Wang et al.
NATURE (2015)
Contacts-based prediction of binding affinity in protein-protein complexes
Anna Vangone et al.
ELIFE (2015)
Integrating protein structural dynamics and evolutionary analysis with Bio3D
Lars Skjrven et al.
BMC BIOINFORMATICS (2014)
Sigma receptors as potential therapeutic targets for neuroprotection
Linda Nguyen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands
Katarzyna A. Gromek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo
Nidhi Kaushal et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Mechanisms of dopamine transporter regulation in normal and disease states
Roxanne A. Vaughan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
X-ray structures of LeuT in substrate-free outward-open and apo inward-open states
Harini Krishnamurthy et al.
NATURE (2012)
OPM database and PPM web server: resources for positioning of proteins in membranes
Mikhail A. Lomize et al.
NUCLEIC ACIDS RESEARCH (2012)
Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity
Nidhi Kaushal et al.
CURRENT NEUROPHARMACOLOGY (2011)
Characterizing protein motions from structure
Charles C. David et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Dopamine release mediated by the dopamine transporter, facts and consequences
Vincent Leviel
JOURNAL OF NEUROCHEMISTRY (2011)
CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice
Nidhi Kaushal et al.
NEUROPHARMACOLOGY (2011)
CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields
K. Vanommeslaeghe et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges
Jacob Eriksen et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types
Jeffery B. Klauda et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo
J. Shawn Goodwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Attenuation of methamphetamine-induced effects through the antagonism of sigma (σ) receptors: Evidence from in vivo and in vitro studies
Rae R. Matsumoto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Software news and updates - CHARNIM-GUI: A web-based grraphical user interface for CHARMM
Sunhwan Jo et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)
Mechanism for alternating access in neurotransmitter transporters
Lucy R. Forrest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bio3d: an R package for the comparative analysis of protein structures
Barry J. Grant et al.
BIOINFORMATICS (2006)
GRAMM-X public web server for protein-protein docking
Andrey Tovchigrechko et al.
NUCLEIC ACIDS RESEARCH (2006)
Involvement of sigma (σ) receptors in the acute actions of methamphetamine:: Receptor binding and behavioral studies
EC Nguyen et al.
NEUROPHARMACOLOGY (2005)
Development and testing of an automated approach to protein docking
A Tovchigrechko et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Oligomerization as a determinant of transporter function and trafficking
HH Sitte et al.
MOLECULAR INTERVENTIONS (2004)
Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures
M Feig et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130
MJ Boulanger et al.
MOLECULAR CELL (2003)
Novel generalized Born methods
MS Lee et al.
JOURNAL OF CHEMICAL PHYSICS (2002)
Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism
ZC Lin et al.
MOLECULAR PHARMACOLOGY (2002)
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence
ND Volkow et al.
JOURNAL OF NEUROSCIENCE (2001)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
Share Paper
